Sartorius Aktiengesellschaft (SWX:SRT3)

Market Cap	12.37B +0.7%
Revenue (ttm)	3.29B +3.2%
Net Income	150.38M +70.1%
EPS	n/a
Shares Out	n/a
PE Ratio	82.24
Forward PE	35.41
Dividend	0.68 (0.32%)
Ex-Dividend Date	Mar 27, 2026

Volume	n/a
Open	200.90
Previous Close	213.70
Day's Range	200.90 - 200.90
52-Week Range	191.85 - 217.70
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 23, 2026

About SWX:SRT3

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture...

• Industry: Laboratory Analytical Instruments
• Founded: 1870
• Employees: 14,242
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: SRT3

Financial Performance

In 2025, SWX:SRT3's revenue was 3.54 billion, an increase of 4.66% compared to the previous year's 3.38 billion. Earnings were 154.90 million, an increase of 84.40%.

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 24, 2026

Data Sources Report a data error